title: cAMP effect on extracellular matrix synthesis in human breast cancer cells.
abstract: The effect of a cAMP derivative (N6, O2-dibutyryl cyclic adenosine 3',5'-monophosphate: dBcAMP) on the cell cycle and on the synthesis of typical extracellular matrix (ECM) components, i.e. collagen and glycosaminoglycans (GAG), was studied in two hormone-responsive human breast cancer cell lines VHB-1 and MCF-7. The data showed that dBcAMP induced a decrease in the proportion of cells in S + G2 + M phases due to an increase of the non-cycling (G0 phase) cell number as revealed by the Ki-67 antigen immunocytochemical study. The collagen synthesis, estimated by [3H] proline incorporation into the cellular proteins followed by an enzymatic digestion with highly purified bacterial collagenase, was not modified by dBcAMP. In contrast, the GAG synthesis, analysed by [3H] glucosamine incorporation, was increased two-fold in the dBcAMP treated cells. As a comparison we also tested 4-hydroxy-Tamoxifen (4-OH-Tam) since it induces similar cell cycle perturbations as dBcAMP. However, we did not observe a stimulation of the GAG synthesis following 4-OH-Tam treatment. These data demonstrated that the increased GAG synthesis is due to cAMP and is not a consequence of perturbations in the cell cycle. We can therefore assume that the ECM modifications induced by dBcAMP may contribute to the growth inhibition of the hormone-responsive human breast cancer cells.
authors.affiliation: Laboratoire d'Endocrinologie Expérimentale, Centre Oscar Lambret, Lille, France.
authors.forename: F
authors.initials: F
authors.lastname: Revillion
authors.forename: B
authors.initials: B
authors.lastname: Vandewalle
authors.forename: B
authors.initials: B
authors.lastname: Lassalle
authors.forename: J
authors.initials: J
authors.lastname: Lefebvre
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology*; D005109:Extracellular Matrix / Q000187:drug effects*; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects*
chemical_list: D006025:Glycosaminoglycans; D013629:Tamoxifen; C016601:afimoxifene; D003094:Collagen; D000242:Cyclic AMP